This patent covers the use of hematopoietic stem cells to generate dendritic cells. The dendritic cells disclosed are able to elicit an antitumor immune response.
View this patent on the USPTO website.
 
  
  
  
  
  
  
  
  
  
  
       
    Add Comment
 Add CommentYou must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.